STEVENSON, Md.--(BUSINESS WIRE)--The law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Gen-Probe Incorporated (NASDAQ: GPRO) (“Gen-Probe”) and other violations of state law by the board of directors of Gen-Probe relating to the proposed acquisition of the company by Hologic, Inc. (“Hologic”). The firm’s investigation seeks to determine, among other things, whether the board breached its fiduciary duties by failing to maximize shareholder value.
On April 30, 2012, Hologic and Gen-Probe announced that they had entered into an agreement providing for Hologic to acquire Gen-Probe for $3.7 billion. Under the terms of the merger agreement, Gen-Probe shareholders will receive $82.75 for each share of Gen-Probe common stock held.
If you currently own shares of Gen-Probe and would like to learn more about the investigation being conducted by Brower Piven, you may email or call Brower Piven, who will, without obligation or cost to you, attempt to answer your questions. You may contact Brower Piven by email at hoffman@browerpiven.com, by calling (410) 415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and other class action cases of over 60 years.